1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends

China CRAMS Market Outlook to 2018 - Manufacturing of APIs and Bulk Drugs to Propel Growth

  • April 2014
  • 39 pages
  • Ken Research Private Limited
Report ID: 2153907

Summary

Table of Contents

EXECUTIVE SUMMARY

The industry research publication titled ‘China CRAMS Market Outlook to 2018 – Manufacturing of APIs and Bulk Drugs to Propel Growth’ presents a comprehensive analysis of market size by value of CRAMS services in China. The report entails the market share analysis and company profiles of major players in the CRAMS industry. The future analysis and segmentation by drugs and devices and therapeutic areas have also been discussed in each of the sub-segment.

The CRAMS industry in China has grown at a CAGR of 15.0% during 2007-2013, registering a market size of USD ~ billion in 2013. The CRAMS industry in China specializes in providing basic intermediaries, APIs and bulk drugs. The industry has emerged as a low-price leader compared to developed industries such as US and Europe. The industry is presently in the growth phase, with a large number of contract research and manufacturing organizations operating in the country. The CMO industry of China accounted for USD 2.6 billion growing at a CAGR of 15.2% during 2007-2013 while the revenues of CRO industry reached USD 1.2 billion in 2013. The increasing capabilities of the Chinese organizations in the research department have been the major reason driving the growth of Chinese CRO industry. Rising incidence of chronic diseases has largely promoted use of contract research and manufacturing services. Nearly 80% of the deaths in China are due to non-communicable diseases and injuries. Some of the most well researched areas in the CRAMS drug market include oncology, cardiovascular diseases, infectious diseases and respiratory diseases.

Oncology reaped the largest revenues for the CRAMS industry of drugs of China with revenues of USD ~ million in 2013, growing at a rate of 13.9% during 2007-2013. Researches for the medication of infectious diseases held the second position with a market size of USD ~ million in 2013, increasing from USD ~ million in 2007. Some of the other emerging research areas of the industry include metabolic disorders, cardiovascular diseases and central nervous system disorders. The Chinese CRAMS industry is highly fragmented with over 500 CROs and more than 100 drug manufacturing sites for APIs and finished products in the country. Some of the leading local players of the industry include Wuxi AppTec, 2Y Chem and Tigermed while the leading global players in the country are Quintiles, Covance and others.

The large and growing population of China is expected to boost up the demand for modern medicines which would increase the investments made by the pharmaceutical companies in the country. The focus of the contract research organizations is expected to shift from chemistry to new areas such as biology, DMPK, formulation and clinical research. Factors such as rise in the exchange rate, labor cost would majorly be responsible for driving the market. The revenue of the market is most likely to advance at a rate of 19.5% during 2013-2018 to reach a size of USD ~ billion by 2018.

KEY TOPICS COVERED IN THE REPORT


- The market size of the China CRAMS market in terms of value in the last years (2007 - 2013)
- China CRAMS market segmentation by CMO and CRO service
- China CRAMS market segmentation by Drugs and Devices
- China CRAMS for Drugs Market Segmentation by Therapeutic Areas
- Trends and Developments in the CRAMS market in China
- Government Rules and Regulations in the CRAMS market in China
- Competitive landscape players operating in CRAMS market of China (such as Tigermed, Wuxi AppTec, Shanghai Pharma Corporation and Others)
- Future projections and macro economic factors of CRAMS market in China.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Osteoporosis Market and Forecast Analysis

  • $ 22000
  • Industry report
  • March 2017
  • by Datamonitor Healthcare

Disease Overview Osteoporosis is the most common metabolic bone disorder, and is characterized by low bone mass accompanied by microarchitectural deterioration of bone tissue. The consequent increase in ...

Systemic Lupus Erythematosus (SLE) Market and Forecast Analysis

  • $ 22000
  • Industry report
  • March 2017
  • by Datamonitor Healthcare

Disease Overview Lupus is a chronic inflammatory autoimmune disorder that can affect many different body systems, including the joints, skin, kidneys, blood cells, brain, heart, and lungs. Systemic lupus ...

Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • $ 6500
  • Industry report
  • February 2017
  • by P&S Market Research

Pipeline Overview Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.